Health Canada said late on Tuesday it has recommended that people with a history of capillary leak syndrome not be vaccinated with drugmaker AstraZeneca’s COVID-19 vaccine.
“Health Canada is updating the product monograph—or label—for the AstraZeneca and COVISHIELD COVID-19/ vaccines to add capillary leak syndrome as a potential side effect, with a warning for patients with a history of capillary leak syndrome to not get the AstraZeneca or COVISHIELD COVID-19 vaccine”, it said in a statement.
RELATED STORIES
FDA recommends suspension of AstraZeneca vaccines on people below 60 years old
Euro medical exec cites link betw…
Keep on reading: Health Canada recommends people with rare blood condition not get AstraZeneca vaccine